Themis Medicare Limited (NSE:THEMISMED)

Market Cap	8.44B -59.0%
Revenue (ttm)	3.37B -21.8%
Net Income	-174.06M
EPS	-1.89
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	0.50 (0.55%)
Ex-Dividend Date	Sep 4, 2025

Volume	12,170
Average Volume	81,845
Open	91.57
Previous Close	91.57
Day's Range	90.11 - 91.57
52-Week Range	75.15 - 195.00
Beta	-0.22
RSI	54.84
Earnings Date	Feb 13, 2026

About Themis Medicare

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolyti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Employees: 1,702
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: THEMISMED

Financial Performance

In fiscal year 2025, Themis Medicare's revenue was 4.06 billion, an increase of 6.22% compared to the previous year's 3.82 billion. Earnings were 298.33 million, a decrease of -31.46%.